stars 1 stars 2 stars 3

Advanced Pharma - Miami is a dedicated Phase I-IV Clinical Research Facility. With our 40,000 sq. ft. turnkey facility we house a 100+ bed capacity Phase I unit with three 6-8 bed IPUs (Intensive Procedural Units) as well as our Phase II-IV group experts. Our principals have participated in clinical trials since 1992 and our team has 50-plus years of combined research experience. Our multi-specialty Physician Investigators enable us to engage in many aspects of Phase I-IV Pharmaceutical, Biotech and Medical Device Trials. Our team of experts is dedicated to sustaining safe, ethical, high-quality medical research so sponsors can exceed their deadline and patients can benefit from the development of new treatments and therapies. We pride ourselves on bringing efficiency, innovation and value to the clinical research process. Our strict adherence to protocol and GCP standards, along with our uniform delivery of quality data guarantees the most efficient and timely outcome in all trials. Our historical patient data confirms that we have outstanding recruitment and retention percentages in the upper 90’s.

Advanced Pharma - Miami Questions

The Advanced Pharma - Miami annual revenue was $17.1 million in 2026.

Samantha Amaba is the President and CEO of Advanced Pharma - Miami.

20 people are employed at Advanced Pharma - Miami.

Advanced Pharma - Miami is based in Miami, Florida.

The NAICS codes for Advanced Pharma - Miami are [62, 62151, 6215, 621].

The SIC codes for Advanced Pharma - Miami are [807, 80].

Top Advanced Pharma - Miami Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users